drugset
Drugs / Inactivated subvirion H7N9 influenza vaccine
last change Jan 2016 re-read 3 minutes ago

Inactivated subvirion H7N9 influenza vaccine

Vaccine

Developed for
swine influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · University of Rochester

Trials 1

today NCT01995695 · Ph 1
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01995695 Oct 2013 → Jan 2016 swine influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Inactivated subvirion H7N9 influenza vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01995695 ↗
Modality Vaccine “A single dose of inactivated subvirion H7N9 influenza vaccine will be administered 3 months later.” NCT01995695 ↗
Route Intramuscular “by intramuscular injection” NCT01995695 ↗